Orchestrators / Life Sciences / AI Sales Coverage
Extends rep reach to HCPs, specialists, rural territories, and LOE brands the field force can’t cover.
Proactive HCP outreach: New indications, FDA label updates, new trial data, payor coverage changes, guideline updates (e.g., GOLD/GINA), delivering the approved promotional message, surveying current practice, confirming understanding and next steps
Long-tail engagement: Entire whitespace of HCPs, and PCP prescribers who never get a rep visit become an addressable channel – agentic selling as a new channel, at ~1/10 the cost of a field call.
Outreach volume: Every target reached within days of a trigger, not once a cycle. LOE brands sustain momentum without traditional field cost.
Return on learning: Insights are captured in real time and relayed back to the brand teams for near real time signals on emerging issues, competitive threats and the drivers of prescription hesitancy.
Field forces are built around a hard constraint: a rep’s day. Coverage concentrates on the highest-decile prescribers, and everyone else—the rural physician, the low-volume specialist, the PCP who writes twice a year, the brand that lost exclusivity—quietly falls off the call plan. Those long-tail prescribers still have patients. This product calls them. It carries the whole portfolio, opens with what changed (a label update, new data, a coverage win), listens to how the HCP practices today, and drives understanding proactively. When interest is real, it books the MSL or the rep. The result is a second sales channel that starts changes the economics of field force coverage.
